Quest Diagnostics (NYSE: DGX)
Quest Diagnostics Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Quest Diagnostics Company Info
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
News & Analysis
Quest Diagnostics EPS Beats Expectations
Quest Diagnostics reported strong third-quarter earnings driven by acquisitions, with revenue surpassing expectations, though profit margins faced pressure.
Mixed Q2 Earnings For Quest Diagnostics
Quest Diagnostics reported stable revenue but mixed profit metrics for Q2 2024.
More Alzheimer's Treatments Are Coming: This Company Can Help With Early Detection
Alzheimer's is a huge problem, and earlier detection could make a big difference.
Want Growing Passive Income? Consider Buying This Stock
This maker of diagnostics tests has delivered 13 years of dividend growth to shareholders.
Is This Healthcare Stock a Buy for Dividend Growth Investors?
This maker of diagnostics tests just announced that it will be sending more cash to its shareholders.
2 Dividend Stocks That Recently Boosted Their Payouts by More Than 7%
These companies may not be finished raising their dividend payments as they both have low payout ratios.
Why Quest Diagnostics Stock Jumped Today
Growth in the lab testing titan's core business is accelerating.
These 3 Companies Are Taking on Monkeypox
A vaccine maker, a therapeutics company, and a medical lab could suit a variety of investor risk profiles.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.